TRX Gold Corporation (T:TRX)
Business Focus: Gold Mining
Oct 05, 2023 10:05 am ET
TRX Gold's Buckreef gold project set to soar with new 1,000-tonne-per-day mill expansion
TRX Gold CEO Stephen Mullowney joined
Steve Darling from Proactive to share news regarding the company's
Buckreef Gold Project.
Jul 20, 2023 11:38 am ET
TRX Gold Q3 results hit record numbers as company remains on track with guidance
TRX Gold CEO Stephen Mullowney joined
Steve Darling from Proactive to share news about the company's
third-quarter performance, demonstrating substantial growth.
May 16, 2023 11:15 am ET
TRX Gold drill results from two key areas of the Buckreef Gold Project show resource potential
TRX Gold CEO Stephen Mullowney joined
Steve Darling from Proactive to share news the company has released
drill results from the Anfield and Eastern Porphyry Zones on the
Buckreef Gold project.
Apr 18, 2023 11:06 am ET
TRX Gold releases 2Q financial results showing highest quarterly production ever
TRX Gold CEO Stephen Mullowney joined
Steve Darling from Proactive to share news the company has put out its
second-quarter financial numbers that continue to show the trend of
record revenue as the new ball mill at Buckreef Gold runs smoothly.
Mar 10, 2023 05:14 am ET
TRX Gold announces company has placed order for a new ball mill for Buckreef Gold Project
TRX Gold CEO Stephen Mullowney joined
Proactive's Steve Darling to share news the company has followed
through on its promise to increase production at the Buckreef Gold
Project. The company has placed an order for a new ball mill.
Jan 19, 2023 04:00 pm ET
TRX Gold releases Q1 2023 results showing another record-breaking quarter
TRX Gold CEO Stephen Mullowney said the company has put out its
2023 first quarter results and is again seeing record numbers.
Mullowney told Proactive that for the third straight quarter, the
company has seen record production, sales, gross profit, and operating
cash flow. Buckreef Gold poured 5,395 ounces of gold and sold 5,754
ounces of gold, both quarterly records. Mullowney also outlined the
guidance and priorities for the company in 2023.
Jan 12, 2023 06:55 am ET
TRX Gold releases positive assay results showing an extension of Buckreef Main Zone
TRX Gold CEO Stephen Mullowney joined Proactive and said the
company has released more drill results from its 24-hole program in
the southwest area of the Buckreef Main zone. Mullowney said the
results showed another extension of known mineralization around 200
metres to the southwest and deeper under the historical South Pit. The
company’s fiscal 2023 program comprises 9,000 metres of diamond
drilling, 13,000 metres of grade control drilling and 10,000 metres of
RC drilling.
Dec 14, 2022 04:59 am ET
TRX Gold's 19-hole metallurgical testing program shows positive results
Proactive Investors Canada
Dec 06, 2022 09:00 am ET
TRX Gold Corp releases strong Q4 and year-end results as company looks for a big 2023
Proactive Investors Canada
Jun 28, 2019 03:05 pm ET
Osisko Closes First Tranche of Share Repurchase Transaction With Orion
Osisko Gold Royalties Ltd ("Osisko" or the "Company") (TSX & NYSE: OR) announces that it has completed the first tranche of the previously announced purchase for cancellation of a total of 12,385,717 common shares of Osisko (the "Share Repurchase")...
Feb 05, 2016 01:17 pm ET
POZEN And Tribute Combine To Create Aralez Pharmaceuticals Inc.
-Transformative Transaction Creates Premier Specialty Pharma Company with a Broad Product Portfolio-
Feb 05, 2016 01:17 pm ET
POZEN And Tribute Combine To Create Aralez Pharmaceuticals Inc.
-Transformative Transaction Creates Premier Specialty Pharma Company with a Broad Product Portfolio-
Feb 04, 2016 05:15 pm ET
S&P Dow Jones Indices Announces Changes to the S&P/TSX Canadian Indices
Tribute Pharmaceuticals Canada Inc. Removed from S&P/TSX Venture Indices
Feb 04, 2016 04:49 pm ET
IIROC Trading Halt - TRX
VANCOUVER, Feb. 4, 2016 /CNW/ - The following issues have been halted by IIROC:
Feb 02, 2016 09:00 am ET
POZEN Inc. Announces Stockholder Approval of its Transaction with Tribute Pharmaceuticals Canada Inc.
-Transaction Expected to Close on or About February 5, 2016-
Feb 02, 2016 09:00 am ET
POZEN Inc. Announces Stockholder Approval of its Transaction with Tribute Pharmaceuticals Canada Inc.
-Transaction Expected to Close on or About February 5, 2016-
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System
for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission.Read less
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Interactive technical study charts by TradingView. Copyright © 2024 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.